{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:38:00Z","timestamp":1786736280558,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Cancer"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijc.ijc_305_18","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T09:10:17Z","timestamp":1567069817000},"page":"216","source":"Crossref","is-referenced-by-count":14,"title":["Role of serum HE4 as a prognostic marker in carcinoma of the ovary"],"prefix":"10.4103","volume":"56","author":[{"given":"Vijay","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikandan","family":"Lakshmanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-509X.263030-1","unstructured":"Stewart BW, Wild CP, editors. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer; 2014."},{"key":"key-10.4103\/0019-509X.263030-2","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Cancer Today; 2018. Available from: http:\/\/gco.iarc.fr\/today. [Last accessed on 2018 Nov 10]."},{"key":"key-10.4103\/0019-509X.263030-3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13277-009-0015-y","article-title":"HE4: A new potential early biomarker for the recurrence of ovarian cancer","author":"Anastasi","year":"2010","journal-title":"Tumor Biol"},{"key":"key-10.4103\/0019-509X.263030-4","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines \u00ae). Ovarian Cancer including Fallopian Tube Cancer\/Primary Peritoneal Cancer (Version 4.2017). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf. [Last accessed on 2017 Nov 20]."},{"key":"key-10.4103\/0019-509X.263030-5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/1096-9098(200012)75:4<264::AID-JSO7>3.0.CO;2-Q","article-title":"Benign condition associated with raised serum CA-125 concentration","author":"Buamah","year":"2000","journal-title":"J Surg Oncol"},{"key":"key-10.4103\/0019-509X.263030-6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1095\/biolreprod45.2.350","article-title":"A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors","author":"Kirchhoff","year":"1991","journal-title":"Biol Reprod"},{"key":"key-10.4103\/0019-509X.263030-7","doi-asserted-by":"crossref","unstructured":"Bouchard D, Morisset D, Bourbonnais Y, Tremblay GM. Proteins with whey-acidic-protein motifs and cancer. Lancet Oncol 2006;7;167-74.","DOI":"10.1016\/S1470-2045(06)70579-4"},{"key":"key-10.4103\/0019-509X.263030-8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-1596-8-11","article-title":"Significance of HE 4 estimation in comparison with CA 125 in diagnosis of ovarian cancer and assessment of treatment response","author":"Hamed","year":"2013","journal-title":"Diagn Pathol"},{"key":"key-10.4103\/0019-509X.263030-9","doi-asserted-by":"crossref","first-page":"12389","DOI":"10.1007\/s13277-014-2553-1","article-title":"Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer","author":"Vallius","year":"2014","journal-title":"Tumor Biol"},{"key":"key-10.4103\/0019-509X.263030-10","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): A randomized trial","author":"Rustin","year":"2010","journal-title":"Lancet"},{"key":"key-10.4103\/0019-509X.263030-11","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.3892\/or.2013.2682","article-title":"Serum HE4 levels combined with CECT imaging improve the management of monitoring women affected by epithelial ovarian cancer","author":"Manganaro","year":"2013","journal-title":"Oncol Rep"},{"key":"key-10.4103\/0019-509X.263030-12","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s13277-015-4031-9","article-title":"The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study","author":"Nassir","year":"2016","journal-title":"Tumor Biol"},{"key":"key-10.4103\/0019-509X.263030-13","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynaecologic Oncology Group study","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0019-509X.263030-14","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0019-509X.263030-15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-2388(200007\/08)19:1<42::AID-SSU7>3.0.CO;2-M","article-title":"Cytoreductive surgery for advanced stages of ovarian cancer","author":"Dauplat","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"key-10.4103\/0019-509X.263030-16","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1245\/s10434-009-0558-6","article-title":"Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer.Meta-analysis of 21 studies?","author":"Kang","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"key-10.4103\/0019-509X.263030-17","first-page":"943","article-title":"Neoadjuvant chemotherapy or primary in stage IIIC or IV ovarian Cancer","author":"Vergote","year":"1 J","journal-title":"N Eng"},{"key":"key-10.4103\/0019-509X.263030-18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2004.09.020","article-title":"CA125 regression during neoadjuvant chemotherapy as an independent prognostic factor for survival in patients with advanced ovarian serous adenocarcinoma","author":"Tate","year":"2005","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/0019-509X.263030-19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00404-010-1655-2","article-title":"The prognostic and predictive value of CA 125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma","author":"Vasudev","year":"2011","journal-title":"Arch Gynecol Obstet"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:39:52Z","timestamp":1786732792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_305_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["263030"],"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_305_18","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}